ArticleVeterinary medicine and science2026
Breed Distribution of the Superoxide Dismutase 1 Gene Polymorphism Associated With Degenerative Myelopathy in a Canine Population From Different Geographical Regions of Türkiye.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BACKGROUND AND
objectiveCanine degenerative myelopathy (CDM) is a progressive neurodegenerative condition that impacts the spinal cord, resulting in paralysis in dogs. CDM is linked to a missense mutation in the superoxide dismutase 1 (SOD1) gene. This study aimed to examine the presence of the SOD1:c.118G>A mutation in the German Shepherd, Golden Retriever, Pomeranian, Toy Poodle and native Kangal Shepherd dog breeds in Türkiye.
methodsBlood samples (n = 161) from five breeds, collected from six provinces across five geographic regions of Türkiye, were tested for the prevalence of the mutant allele associated with CDM. All dogs were clinically healthy and sampled for genetic testing. Genotyping was performed using the PCR-RFLP method and gel electrophoresis.
resultsGenotyping of dogs revealed that 141 had the homozygous wild-type genotype (GG), 20 were heterozygous carriers (AG), and there were no homozygous mutant (AA) individuals. The mutant A allele was determined in Kangal Shepherd, German Shepherd and Toy Poodle dog breeds. The frequency of the mutant allele in the investigated population was identified as 0.062. It was determined that the mutant allele, which was not previously reported in the Kangal Shepherds, was present, and the mutant allele frequency revealed 0.057.
conclusionsThe SOD1:c.118G>A mutation is present in dog breeds in Türkiye, and is also detected in the Kangal Shepherd, an ancient breed. This finding underscores the importance of genetic testing in dogs, as it is crucial to prevent the spread of mutations in different canine populations. Carrier dogs can be clinically identified to prevent breeding and reduce CDM incidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.